Experimental study on effect of leflunomide on rat models of endometriosis
article
OA: closed
CC0
AI-generated summary
Leflunomide treatment significantly reduced focal volume and inhibited ectopic endometrium growth in rat endometriosis models by downregulating TNF-α and NF-κB expression.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Objective:To observe the effect of leflunomide on focal growth behaviors of rat models of endometriosis,provide a basis for immune therapy of endometriosis.Methods:Autologous transplantation was used to established rat models of endometriosis;on the third week after transplantation,the rats in treatment group were treated with leflunomide,35 mg·kg-1·d-1 for three weeks;the rats in control group were treated with normal saline,1 ml·kg-1·d-1 for three weeks;the focal volumes before and after treatment were measured,radioimmunoassay was used to detect the expression of TNF-α,and immunohistochemical method was used to detect the expression of NF-κB.Results:The focal volume of treatment group was significantly smaller than that of control group(P0.05);histopathological results showed that the growth of ectopic endometrium in treatment group was inhibited or necrosis,the blood supply of focal tissues was inadequate;the expression levels of TNF-α and NF-κB in treatment group were significantly lower than those in control group(P0.05).Conclusion:Leflunomide can inhibit the focal growth of endometrium in rat models,it is feasible to treat endometriosis by immune regulation.
My notes (saved in your browser only)
Condition tags
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK